Improving Sleep in Gynecologic Cancer Survivors

NCT ID: NCT05044975

Last Updated: 2025-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

95 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-11

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study has two parts.

In Part 1, 15 gynecologic cancer survivors will receive three candidate intervention components known to reduce sleep disturbance (i.e., sleep restriction, stimulus control, systematic light exposure) simultaneously for six weeks. Participants will then complete semi-structured individual interviews to provide feedback about barriers to and facilitators of intervention adherence. Results of Part 1 will inform the design and delivery of the candidate components in Part 2.

In Part 2, a 2\^3 full factorial design will be followed to randomize 80 gynecologic cancer survivors to one of eight six-week intervention conditions reflecting all possible combinations of the three candidate intervention components.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disturbance Gynecologic Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sleep restriction, Stimulus control, and Systematic light exposure

Group Type EXPERIMENTAL

Sleep restriction

Intervention Type BEHAVIORAL

Participants will receive sleep restriction intervention

Stimulus control

Intervention Type BEHAVIORAL

Participants will receive stimulus control intervention

Systematic light exposure

Intervention Type BEHAVIORAL

Participants will receive systematic light exposure intervention

Sleep restriction and Stimulus control

Group Type EXPERIMENTAL

Sleep restriction

Intervention Type BEHAVIORAL

Participants will receive sleep restriction intervention

Stimulus control

Intervention Type BEHAVIORAL

Participants will receive stimulus control intervention

Sleep restriction and Systematic light exposure

Group Type EXPERIMENTAL

Sleep restriction

Intervention Type BEHAVIORAL

Participants will receive sleep restriction intervention

Systematic light exposure

Intervention Type BEHAVIORAL

Participants will receive systematic light exposure intervention

Stimulus control and Systematic light exposure

Group Type EXPERIMENTAL

Stimulus control

Intervention Type BEHAVIORAL

Participants will receive stimulus control intervention

Systematic light exposure

Intervention Type BEHAVIORAL

Participants will receive systematic light exposure intervention

Sleep Restriction

Group Type EXPERIMENTAL

Sleep restriction

Intervention Type BEHAVIORAL

Participants will receive sleep restriction intervention

Stimulus control

Group Type EXPERIMENTAL

Stimulus control

Intervention Type BEHAVIORAL

Participants will receive stimulus control intervention

Systematic light exposure

Group Type EXPERIMENTAL

Systematic light exposure

Intervention Type BEHAVIORAL

Participants will receive systematic light exposure intervention

Sleep tracking

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sleep restriction

Participants will receive sleep restriction intervention

Intervention Type BEHAVIORAL

Stimulus control

Participants will receive stimulus control intervention

Intervention Type BEHAVIORAL

Systematic light exposure

Participants will receive systematic light exposure intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* History of Stage I, II, or III gynecologic cancer
* Age 18+ years
* English language proficiency
* Current sleep disturbance demonstrated by a Pittsburgh Sleep Quality Index (PSQI) score \> 5
* Usual sleep onset time between 9:00PM and 3:00AM
* Reliable telephone and Internet access

Exclusion Criteria

* Stage IV disease
* Diagnosed or suspected psychiatric or medical condition that may interfere with participation (e.g., psychosis, dementia, bipolar disorder, abuse of alcohol or illicit substances within the past 6 months, narrow angle glaucoma, retinal disorders, epilepsy or a similar condition)
* Diagnosed sleep apnea, narcolepsy, periodic limb movement disorder, or restless legs syndrome unless well controlled
* Use of medications that may be contraindications for study procedures due to safety concerns or due to potential impact on intervention efficacy or assessment validity (e.g., sedatives/hypnotics), to be identified on a case-by-case basis
* Shift worker
* Severe physical or cognitive impairment (≥ 2 errors on a brief six-item version of the Mini Mental State Exam \[MMSE\] or Patient Reported Functional Status \[PRFS\] score \> 2, which is based on the Eastern Cooperative Oncology Group \[ECOG\]but has been modified to be in lay language)
* Plans to travel across 3 or more meridians/time zones during the 6 intervention weeks or plans to cross any meridians/time zones during the 2 weeks leading up to wearing an actiwatch.
* History of a primary diagnosis of a distinct non-gynecologic or non-skin cancer other than a non-melanoma skin cancer within the 5 years prior to enrollment
* For participants with Stage III ovarian cancer: less than 2 years post-completion of primary gynecologic cancer treatment and/or less than 60 days post-surgery. For patients with any other gynecologic cancer/stage: less than 30 days post-completion of primary gynecologic cancer treatment and/or less than 60 days post-surgical intervention (e.g., hysterectomy)
* Male
* Have received CBT-I or systematic bright light therapy within the past 6 months
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Arizona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rina Fox

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arizona College of Nursing

Tucson, Arizona, United States

Site Status

Northwestern University Feinberg School of Medicine

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Fox RS, Gaumond JS, Zee PC, Kaiser K, Tanner EJ, Ancoli-Israel S, Siddique J, Penedo FJ, Wu LM, Reid KJ, Parthasarathy S, Badger TA, Rini C, Ong JC. Optimizing a Behavioral Sleep Intervention for Gynecologic Cancer Survivors: Study Design and Protocol. Front Neurosci. 2022 Mar 4;16:818718. doi: 10.3389/fnins.2022.818718. eCollection 2022.

Reference Type DERIVED
PMID: 35310101 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K08CA247973

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STU00213356

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Women's Function After Pelvic Radiation
NCT04544735 ACTIVE_NOT_RECRUITING NA
Dyadic Sleep Study
NCT06569693 RECRUITING NA
Guided Imagery & Music in Cancer
NCT03936075 UNKNOWN NA